AAV8-mediated gene therapy of Pompe mice normalizes muscle pathology and corrects motor function deficits

被引：0
|
作者：
Cheng, S. H. [1 ]
Zhao, M. A. [1 ]
Bercury, S. [1 ]
Fidler, J. A. [1 ]
Foley, J. W. [1 ]
Ryan, S. [1 ]
Taksir, T. [1 ]
Shihabuddin, L. S. [1 ]
Ziegler, R. J. [1 ]
机构：
[1] Genzyme Corp, Framingham, MA 01701 USA
来源：
JOURNAL OF INHERITED METABOLIC DISEASE | 2006年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：30 / 30
页数：1
相关论文
共 50 条
  • [31] AAV8-Mediated Gene Therapy Rescues Retinal Degeneration Phenotype in a Tlcd3b Knockout Mouse Model
    Qian, Xinye
    Liu, Hehe
    Fu, Shangyi
    Lu, Jiaxiong
    Hung, Yu-Ting
    Turner, Cassidy
    Gu, Haiwei
    Chen, Rui
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (03)
  • [32] Ad- and AAV8-mediated ABCA1 gene therapy in a murine model with retinal ischemia/reperfusion injuries
    Luo, Jing
    Wang, Shengli
    Zhou, Zhenlong
    Zhao, Yin
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2021, 20 : 551 - 558
  • [33] Efficacious Androgen Hormone Administration in Combination with AAV Vector-Mediated Gene Therapy in Female Mice with Pompe Disease
    Han, Sang-oh
    Mapatano, Sweet Hope
    Li, Songtao
    Brooks, Elizabeth
    Koeberl, Dwight
    MOLECULAR THERAPY, 2017, 25 (05) : 193 - 194
  • [34] AAV Gene Therapy Utilizing Glycosylation-Independent Lysosomal Targeting Tagged GAA in the Hypoglossal Motor System of Pompe Mice
    Doyle, Brendan M.
    Turner, Sara M. F.
    Sunshine, Michael D.
    Doerfler, Phillip A.
    Poirier, Amy E.
    Vaught, Lauren A.
    Jorgensen, Marda L.
    Falk, Darin J.
    Byrne, Barry J.
    Fuller, David D.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2019, 15 : 194 - 203
  • [35] Assessment of toxicity and biodistribution of recombinant AAV8 vector-mediated immunomodulatory gene therapy in mice with Pompe disease (vol 2, 15002, 2015)
    Wang, Gensheng
    Young, Sarah P.
    Bali, Deeksha
    Hutt, Julie
    Li, Songtao
    Benson, Janet
    Koeberl, Dwight D.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2015, 2
  • [36] Systemic Gene Therapy of Lysosomal Storage Disorders: Efforts To Improve AAV8-Mediated Expression from Non-Human Primate Liver
    Nietupski, Jennifer B.
    Ziegler, Robin
    Hurlbut, Gregory
    Luo, Zhengyu
    Ashe, Karen
    Bree, Mark
    Foley, Joseph
    Meyers, Elizabeth
    Pande, Nilesh
    Cheng, Seng H.
    Marshall, John
    Scheule, Ron K.
    MOLECULAR THERAPY, 2009, 17 : S339 - S340
  • [37] AAV8-mediated sVEGFR2 and sVEGFR3 gene therapy combined with chemotherapy reduces the growth and microvasculature of human ovarian cancer and prolongs the survival in mice
    Kujala, Anni
    Valkonen, Elina
    Sallinen, Hanna
    Tuppurainen, Laura
    Laakso, Hanne
    Yla-Herttuala, Elias
    Liimatainen, Timo
    Kujala, Jouni
    Jokelainen, Otto
    Sironen, Reijo
    Anttila, Maarit
    Yla-Herttuala, Seppo
    FRONTIERS IN MEDICINE, 2022, 9
  • [38] Assessment of toxicity and biodistribution of recombinant AAV8 vector-mediated immunomodulatory gene therapy in mice with Pompe disease (vol 1, pg 14018, 2014)
    Wang, Gensheng
    Young, Sarah P.
    Bali, Deeksha
    Hutt, Julie
    Li, Songtao
    Benson, Janet
    Koeberl, Dwight D.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2019, 13 : 493 - 493
  • [39] AAV Type 8 Mediated Bone-Targeted and Muscle Directed Neonatal Gene Therapy for Hypophosphatasia
    Miyake, Koichi
    Matsumoto, Tae
    Miyake, Noriko
    Orimo, Hideo
    Fukunaga, Yoshitaka
    Shimada, Takashi
    JOURNAL OF GENE MEDICINE, 2014, 16 (7-8): : 274 - 275
  • [40] Dual-function AAV gene therapy reverses late-stage Canavan disease pathology in mice
    Frohlich, Dominik
    Kalotay, Elizabeth
    von Jonquieres, Georg
    Bongers, Andre
    Lee, Brendan
    Suchowerska, Alexandra K.
    Housley, Gary D.
    Klugmann, Matthias
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2022, 15
12345